Symbols / MTEM
MTEM Chart
About
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas. On April 20, 2025, Molecular Templates, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | — |
| Enterprise Value | 1.37M | Income | -15.63M | Sales | 25.47M |
| Book/sh | — | Cash/sh | 1.47 | Dividend Yield | — |
| Payout | 0.00% | Employees | 62 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | -0.10 | EV/Sales | 0.05 | Quick Ratio | 1.36 |
| Current Ratio | 1.56 | Debt/Eq | 155.07 | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -91.70% | Earnings | 2024-08-14 16:00 | ROA | -37.88% |
| ROE | — | ROIC | — | Gross Margin | -14.75% |
| Oper. Margin | -14.50% | Profit Margin | -61.35% | Shs Outstand | — |
| Shs Float | 5.67M | Short Float | 6.45% | Short Ratio | 0.01 |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | 1.53 | Avg Volume | — | Volume | — |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $0.11 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Molecular Templates Faces Dual Nasdaq Compliance Warnings Over Filing, Stock Price - Stock Titan Mon, 02 Dec 2024 08
- Molecular Templates, Inc. Faces Delisting from Nasdaq Due to Compliance Issues - Nasdaq hu, 19 Dec 2024 08
- Why Molecular Templates (MTEM) Stock Is Down 77% Today - TradingView Mon, 14 Oct 2024 07
- Molecular Templates Announces Leadership Changes and Operational Wind Down - TipRanks hu, 02 Jan 2025 08
- Why Molecular Templates Stock Crashed Today - The Motley Fool Mon, 05 Apr 2021 07
- Molecular Templates Forges Cancer Deal with BMS Worth up to $1.3 Billion - BioSpace Fri, 12 Feb 2021 08
- Molecular Templates Is Melting Down: Is MTEM the Next Meme Stock Comeback or Just Over? - AD HOC NEWS ue, 10 Feb 2026 08
- Molecular Templates Inc Announces Layoffs, CMO Resignation - TipRanks Fri, 12 Apr 2024 07
- Molecular Templates | $MTEM Stock | Shares Gap Sharply Higher on Takeda Partnership Deal - warriortradingnews.com Wed, 19 Sep 2018 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1279820 | 845833 | — | Sale at price 0.66 per share. | BIOTECH TARGET N V | Beneficial Owner of more than 10% of a Class of Security | — | 2024-11-14 00:00:00 | D |
| 1 | 175000 | 332500 | — | Stock Award(Grant) at price 1.90 per share. | LALANDE KEVIN M | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2024-04-02 00:00:00 | I |
| 2 | 250000 | 475000 | — | Purchase at price 1.90 per share. | BIOTECH TARGET N V | Beneficial Owner of more than 10% of a Class of Security | — | 2024-04-02 00:00:00 | D |
| 3 | 4255319 | 2000000 | — | Purchase at price 0.47 per share. | BIOTECH TARGET N V | Beneficial Owner of more than 10% of a Class of Security | — | 2023-07-17 00:00:00 | D |
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MTEM
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|